A new oral GLP-1 medication can help adults with obesity and Type 2 diabetes lose more weight and improve their blood sugar ...

An innovative new pill could soon offer a new and affordable weight management treatment, following a successful clinical trial involving University of Bristol researchers. The results are published ...

Oct 15 (Reuters) - Eli Lilly's (LLY.N), opens new tab experimental weight-loss pill showed superior blood sugar control in diabetic patients across two late-stage trials, the company said on Wednesday ...

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) currently available for the treatment of obesity are administered as a peptide-based subcutaneous injection, but oral (non-peptide) versions would ...

A massive international study has shown that the experimental oral obesity drug orforglipron can help patients shed over 10% of their body weight, with nearly one in five losing 20% or more. Unlike ...

An oral weight loss pill has performed well in clinical trials, positioning it as a potential alternative to injectable GLP-1 medications like Ozempic and Wegovy. The Eli Lilly drug, called ...

This could really move the needle in the GLP-1 weight loss market. Semaglutide, the active ingredient in Ozempic and Wegovy, is injected into the fatty tissue just under the skin of the stomach, thigh ...

An effective weight-loss pill to rival injectable drugs like Ozempic and Zepbound might be on the horizon, clinical trial results show. An experimental GLP-1 pill called orforglipron promoted ...

Novo Nordisk's experimental daily Wegovy pill helped patients lose about as much weight as its weekly injection, according to data from a late-stage trial. The pill has already been sent to U.S.

Novo Nordisk said that patients taking a pill form of Wegovy in a clinical trial lost about as much weight as those who get the shot version, fueling new optimism that oral GLP-1 drugs could expand an ...

Novo Nordisk’s NOVO.B2.34%increase; green up pointing triangle experimental daily Wegovy pill helped patients lose about as much weight as its weekly injection, according to data from a late-stage ...

A GLP-1 drug called orforglipron—taken in pill form once a day—has been shown to help with "significant" weight loss in people with obesity. In a multinational trial of around 3,000 adults, a 72-week ...